Anton Buchner
Impact in
- Oncology top 10%
- Neutropenia and Cancer Infections
-
- Inflammatory mediators and NSAID effects
Papers in
- Co-authors
- Peter Bias (22 shared papers)Oleg Gladkov (9 shared papers)Igor Bondarenko (6 shared papers)Stefan Laufer (1 shared paper)Udo Müller (4 shared papers)Constantin Volovăț (5 shared papers)Jean‐Yves Reginster (1 shared paper)Sergei Tjulandin (2 shared papers)
In The Last Decade
Anton Buchner
28 papers receiving 355 citations
Peers
Comparison fields: 5 of 55
- Oncology 214
- Pharmacology 73
- Genetics 105
- Hematology 40
- Clinical Biochemistry 24
Countries citing papers authored by Anton Buchner
This map shows the geographic impact of Anton Buchner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Buchner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Buchner more than expected).
Fields of papers citing papers by Anton Buchner
This network shows the impact of papers produced by Anton Buchner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Buchner. The network helps show where Anton Buchner may publish in the future.
Co-authors
The 25 scholars most cited alongside Anton Buchner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 77 | |
| 2 | 2013 | 73 | |
| 3 | 2014 | 26 | |
| 4 | 2013 | 21 | |
| 5 | 2010 | 18 | |
| 6 | 2014 | 18 | |
| 7 | 2015 | 17 | |
| 8 | First clinical results of licofelone (ml3000), an inhibitor of COX-1, COX-2 and 5-LOX, for the treatment of osteoarthritis | 2002 | 14 |
| 9 | 2015 | 14 | |
| 10 | 2011 | 13 | |
| 11 | 2018 | 13 | |
| 12 | 2015 | 12 | |
| 13 | 2010 | 9 | |
| 14 | 2020 | 8 | |
| 15 | 2012 | 8 | |
| 16 | 2016 | 7 | |
| 17 | 2012 | 7 | |
| 18 | 2016 | 4 | |
| 19 | 2012 | 4 | |
| 20 | 2011 | 4 |
About Anton Buchner
Anton Buchner is a scholar working on Oncology, Genetics, Hematology, Pharmacology and Epidemiology, having authored 29 papers that have together received 382 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (17 papers), Blood disorders and treatments (8 papers), Erythropoietin and Anemia Treatment (4 papers), Inflammatory mediators and NSAID effects (2 papers), Iron Metabolism and Disorders (2 papers), Cancer Treatment and Pharmacology (2 papers), Bacterial Identification and Susceptibility Testing (2 papers) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Oncology (214 citations), Pharmacology (73 citations), Genetics (105 citations), Hematology (40 citations) and Clinical Biochemistry (24 citations). Anton Buchner has collaborated with scholars based in Russia, Germany and Ukraine. Frequent co-authors include Peter Bias, Oleg Gladkov, Igor Bondarenko, Stefan Laufer, Udo Müller, Constantin Volovăț, Jean‐Yves Reginster, Sergei Tjulandin, Noa Avisar and Steve Barash. Their work appears in journals such as Supportive Care in Cancer, Journal of Clinical Oncology, Current Medical Research and Opinion, Clinical Breast Cancer and Journal of Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.